생분해성 스텐트 시장 : 제품 유형별, 재료 유형별, 최종사용자별, 지역별

The global biodegradable stents size is estimated to be at US$ 388.9 Mn in 2023 and is expected to reach US$ 634.7 Mn by 2030, growing at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030.

Figure 1. Global Biodegradable Stents Market Share (%), by Region, 2023

The biodegradable stents market is rapidly evolving within the broader medical devices industry. Biodegradable stents, also known as bioresorbable or bioabsorbable stents, are used in the treatment of coronary artery diseases or peripheral artery diseases. These stents are designed to open up blocked arteries and gradually dissolve in the body over a period of time, eliminating the need for a permanent metallic implant and reducing the risk of complications associated with traditional stents. The global biodegradable stents market is driven by several factors including the rising prevalence of cardiovascular diseases, advancements in technology, and the growing preference for minimally invasive procedures. The market is also influenced by the increasing demand for better and safer alternatives to traditional stents, which can cause long-term complications such as thrombosis and restenosis. Furthermore, growing awareness about the benefits of biodegradable stents, such as their ability to restore the natural movement and function of the artery, is also contributing to the growth of the market. However, the high cost of these stents and the stringent regulatory approval process may hinder the market growth to some extent. Despite these challenges, the biodegradable stents market holds immense potential for growth, with numerous opportunities for existing players and new entrants. The market is characterized by intense competition, with key players focusing on research and development activities to introduce innovative products and gain a competitive edge. The future of the biodegradable stents market looks promising, with increasing adoption in the healthcare sector and growing recognition of their benefits over traditional stents.

Market Dynamics:

The global biodegradable stents market is primarily driven by the growing preference for minimally invasive procedures, rising geriatric population worldwide prone to cardiac ailments, and increasing incidence of coronary and peripheral artery diseases. Additionally, favorable reimbursement policies and regulatory approvals are promoting the adoption of biodegradable stents. However, the high cost of biodegradable stents compared to conventional metallic stents and lack of long-term performance data are the major factors negatively impacting the market growth.

Key Features of the Study:

• This report provides an in-depth analysis of the global biodegradable stents market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global biodegradable stents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Boston Scientific Corporation, Abbott, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc., Arterial Remodeling Technologies SA.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global biodegradable stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biodegradable stents market

Detailed Segmentation:

• Global Biodegradable Stents Market Segmentation, By Product Type:
  • Coronary Stents
  • Peripheral Stents
• Global Biodegradable Stents Market Segmentation, By Material Type:
  • Polymer-based Stents
  • Metallic Stents
• Global Biodegradable Stents Market Segmentation, By End User:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
• Global Biodegradable Stents Market Segmentation, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profile:
  • Boston Scientific Corporation
  • Abbott
  • Kyoto Medical Planning Co., Ltd.
  • QualiMed
  • Elixir Medical Corporation
  • ENDOCOR GmbH
  • BIOTRONIK SE & Co. KG
  • Amaranth Medical, Inc.
  • Arterial Remodeling Technologies SA.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Biodegradable Stents, By Product Type
  • Market Biodegradable Stents, By Material Type
  • Market Biodegradable Stents, By End User
  • Market Biodegradable Stents, By Geography/Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Growing adoption of minimally invasive procedures
  • Restraints
• High cost of biodegradable stents
  • Opportunities
• Technological advancements
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Biodegradable Stents Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Biodegradable Stents Market, By Product Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Coronary Stents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Peripheral Stents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global Biodegradable Stents Market, By Material Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Polymer-based Stents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Metallic Stents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Biodegradable Stents Market, By End User, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Biodegradable Stents Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019 - 2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
• South Africa
• Central Africa
• North Africa

9. Competitive Landscape

• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Kyoto Medical Planning Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• QualiMed
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Elixir Medical Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• ENDOCOR GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BIOTRONIK SE & Co. KG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Amaranth Medical, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Arterial Remodeling Technologies SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us